Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001390055 | SCV001591642 | pathogenic | Myasthenic syndrome, congenital, 22 | 2017-07-30 | criteria provided, single submitter | clinical testing | This variant is a gross deletion of the genomic region encompassing exons 9-14 of the PREPL gene. The 5' boundary is likely confined to intron 8. The 3' end of this event extends through the termination codon beyond the assayed region for this gene and encompasses exons 5-10 of the SLC3A1 gene. While this deletion is not anticipated to result in nonsense mediated decay, it is expected to create a truncated protein product or disrupt mRNA translation. A deletion encompassing exons 9-14 of the PREPL gene and exons 5-10 of the SLC3A1 gene has been reported in an individual affected with hypotonia-cystinuria syndrome (PMID: 24610330). For these reasons, this variant has been classified as Pathogenic. |